Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001179110-21-009263

Options or other derivatives

  • Chief Accounting Officer acquired 700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R Chief Accounting Officer 2021-10-04 Grant or award · Restricted Share Units +700 700 D: show line 1 in the form
Loading xslF345X03/edgar.xml…